← Back to screener

BIO-TECHNE Corp TECH

Rank #1484 · Nasdaq · $11.4B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
47.6
P/E
67.7
P/B
5.78
ROE
8.5%
Op. Margin
17.8%
Debt Ratio
30%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E 67.7x, P/B 5.78x. Ranks in the top 63% of the universe.

Profitability ★★★☆☆
Good

ROE 8.5%. Ranks in the top 36% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 30%. Ranks in the top 17% of the universe. Under 100% is generally considered a safe level.

Growth ★★☆☆☆
Average

Revenue growth of 2.0% year over year. Ranks in the top 59% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.2B$0.1B$0.5B–-3
2012–$0.2B$0.1B$0.5B–14
2013–$0.2B$0.1B$0.5B–23
2014–$0.2B$0.1B$0.6B–23
2015–$0.0B$0.1B$0.7B–15
2016–$0.2B$0.1B$0.7B–17
2017–$0.1B$0.1B$0.8B–42
2018$0.5B$0.2B$0.1B$0.8B30.284
2019$0.6B$0.1B$0.1B$0.9B21.481
2020$0.6B$0.1B$0.1B$0.9B21.298
2021$0.7B$0.1B$0.1B$1.4B20.547
2022$0.7B$0.2B$0.2B$1.6B21.345
2023$0.9B$0.2B$0.1B$1.7B25.535
2024$1.1B$0.3B$0.3B$2.0B26.834
2025$1.1B$0.3B$0.3B$1.7B26.359
2026$1.2B$0.2B$0.2B$2.0B17.830

← See the full screener